482 related articles for article (PubMed ID: 15082014)
21. Quality of life after laparoscopic and open retroperitoneal lymph node dissection in clinical Stage I nonseminomatous germ cell tumor: a comparison study.
Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Becht E
Urology; 2006 Jul; 68(1):154-60. PubMed ID: 16820195
[TBL] [Abstract][Full Text] [Related]
22. Minimally Invasive Retroperitoneal Lymphadenectomy: Current Status.
Kunit T; Janetschek G
Urol Clin North Am; 2015 Aug; 42(3):321-9. PubMed ID: 26216819
[TBL] [Abstract][Full Text] [Related]
23. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update.
Yoon GH; Stein JP; Skinner DG
Urol Oncol; 2005; 23(3):168-77. PubMed ID: 15907716
[TBL] [Abstract][Full Text] [Related]
24. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
Fornara P; Hoda MR
Eur Urol; 2008 Nov; 54(5):1015-6. PubMed ID: 18722706
[No Abstract] [Full Text] [Related]
25. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
Pizzocaro G
Eur Urol; 2008 Nov; 54(5):1017-8. PubMed ID: 18722705
[No Abstract] [Full Text] [Related]
26. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
Albers P
Eur Urol; 2008 Nov; 54(5):1016-7. PubMed ID: 18722703
[No Abstract] [Full Text] [Related]
27. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
Mottet N
Eur Urol; 2008 Nov; 54(5):1018-9. PubMed ID: 18722702
[No Abstract] [Full Text] [Related]
28. [Transperitoneal laparoscopic modified lymph node dissection for clinical stage I nonseminomatous germ cell testicular carcinoma].
Wu HY; Zhang DH; Li XD; Ding GQ; Chen YB
Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1118-20. PubMed ID: 19157236
[TBL] [Abstract][Full Text] [Related]
29. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
Stephenson AJ; Klein EA
BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
[TBL] [Abstract][Full Text] [Related]
30. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
[TBL] [Abstract][Full Text] [Related]
31. Retroperitoneal laparoscopic lymph node dissection (RPLND) in testicular cancer.
Vidal-Mora I; Castillo OA
Arch Esp Urol; 2010 Jun; 63(5):373-9. PubMed ID: 20587842
[TBL] [Abstract][Full Text] [Related]
32. Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer.
Nielsen ME; Lima G; Schaeffer EM; Porter J; Cadeddu JA; Tuerk I; Kavoussi LR
Urology; 2007 Dec; 70(6):1168-72. PubMed ID: 18158040
[TBL] [Abstract][Full Text] [Related]
33. Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update.
Gardner MW; Roytman TM; Chen C; Brandes SB; Kibel AS; Grubb RL; Bhayani SB; Figenshau RS
J Endourol; 2011 Nov; 25(11):1753-7. PubMed ID: 21936630
[TBL] [Abstract][Full Text] [Related]
34. Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell testicular cancer.
Underwood W; Kim HL
BJU Int; 2012 Jan; 109(2):281-5. PubMed ID: 21631699
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer.
Skolarus TA; Bhayani SB; Chiang HC; Brandes SB; Kibel AS; Landman J; Figenshau RS
J Endourol; 2008 Jul; 22(7):1485-9. PubMed ID: 18613781
[TBL] [Abstract][Full Text] [Related]
36. [Post-chemotherapy laparoscopic retroperitoneal lymph node dissection in low volume residual germ cell cancer: a technique to reduce morbidity].
Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C
Urologe A; 2013 Aug; 52(8):1097-103. PubMed ID: 23416965
[TBL] [Abstract][Full Text] [Related]
37. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
Heidenreich A; Thüer D; Polyakov S
Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
[TBL] [Abstract][Full Text] [Related]
38. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
[TBL] [Abstract][Full Text] [Related]
39. Controversial technology: the Chunnel and the laparoscopic retroperitoneal lymph node dissection (RPLND).
Schwartz MJ; Kavoussi LR
BJU Int; 2010 Oct; 106(7):950-9. PubMed ID: 20840317
[TBL] [Abstract][Full Text] [Related]
40. Long-term results of laparoscopic retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testicular cancer.
Neyer M; Peschel R; Akkad T; Springer-Stöhr B; Berger A; Bartsch G; Steiner H
J Endourol; 2007 Feb; 21(2):180-3. PubMed ID: 17338618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
